Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system

被引:115
|
作者
Laczy, Boglarka [1 ]
Hill, Bradford G. [2 ,3 ]
Wang, Kai [4 ]
Paterson, Andrew J. [4 ]
White, C. Roger [1 ,3 ,5 ]
Xing, Dongqi [1 ,6 ]
Chen, Yiu-Fai [1 ,6 ]
Darley-Usmar, Victor [2 ,5 ,6 ]
Oparil, Suzanne [1 ,3 ,5 ,6 ]
Chatham, John C. [1 ,3 ,5 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA
[5] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL 35294 USA
[6] Univ Alabama Birmingham, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
hexosamine biosynthesis; protein O-glycosylation; beta-N-acetylglucosamine transferase; diabetes mellitus; LINKED N-ACETYLGLUCOSAMINE; HUMAN GLUTAMINE-FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE; ISCHEMIA-REPERFUSION INJURY; CAPACITATIVE CALCIUM-ENTRY; INHIBITOR-1 GENE PROMOTER; ENDOTHELIAL GROWTH-FACTOR; IMPAIRED SERCA FUNCTION; BETA-D-GLUCOSAMINIDASE; NITRIC-OXIDE SYNTHASE; MUTATIONAL HOT-SPOT;
D O I
10.1152/ajpheart.01056.2008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Laczy B, Hill BG, Wang K, Paterson AJ, White CR, Xing D, Chen Y, Darley-Usmar V, Oparil S, Chatham JC. Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system. Am J Physiol Heart Circ Physiol 296: H13-H28, 2009. First published November 21, 2008; doi: 10.1152/ajpheart.01056.2008. - The posttranslational modification of serine and threonine residues of nuclear and cytoplasmic proteins by the O-linked attachment of the monosaccharide beta-N-acetylglucosamine (O-GlcNAc) is a highly dynamic and ubiquitous protein modification. Protein O-GlcNAcylation is rapidly emerging as a key regulator of critical biological processes including nuclear transport, translation and transcription, signal transduction, cytoskeletal reorganization, proteasomal degradation, and apoptosis. Increased levels of O-GlcNAc have been implicated as a pathogenic contributor to glucose toxicity and insulin resistance, which are both major hallmarks of diabetes mellitus and diabetes-related cardiovascular complications. Conversely, there is a growing body of data demonstrating that the acute activation of O-GlcNAc levels is an endogenous stress response designed to enhance cell survival. Reports on the effect of altered O-GlcNAc levels on the heart and cardiovascular system have been growing rapidly over the past few years and have implicated a role for O-GlcNAc in contributing to the adverse effects of diabetes on cardiovascular function as well as mediating the response to ischemic injury. Here, we summarize our present understanding of protein O-GlcNAcylation and its effect on the regulation of cardiovascular function. We examine the pathways regulating protein O-GlcNAcylation and discuss, in more detail, our understanding of the role of O-GlcNAc in both mediating the adverse effects of diabetes as well as its role in mediating cellular protective mechanisms in the cardiovascular system. In addition, we also explore the parallels between O-GlcNAc signaling and redox signaling, as an alternative paradigm for understanding the role of O-GlcNAcylation in regulating cell function.
引用
收藏
页码:H13 / H28
页数:16
相关论文
共 50 条
  • [1] Protein O-GlcNAcylation in cardiovascular diseases
    Hui-fang Wang
    Yi-xuan Wang
    Yu-ping Zhou
    Yun-peng Wei
    Yi Yan
    Ze-jian Zhang
    Zhi-cheng Jing
    Acta Pharmacologica Sinica, 2023, 44 : 8 - 18
  • [2] Protein O-GlcNAcylation in cardiovascular diseases
    Wang, Hui-fang
    Wang, Yi-xuan
    Zhou, Yu-ping
    Wei, Yun-peng
    Yan, Yi
    Zhang, Ze-jian
    Jing, Zhi-cheng
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (01) : 8 - 18
  • [3] O-Glcnacylation & Phosphorylation have Extensive Crosstalk: A New Paradigm for Signaling
    Hart, Gerald W.
    GLYCOBIOLOGY, 2010, 20 (11) : 1454 - 1454
  • [4] Protein O-GlcNAcylation and Cardiovascular (Patho)physiology
    Marsh, Susan A.
    Collins, Helen E.
    Chatham, John C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (50) : 34449 - 34456
  • [5] Extensive crosstalk between O-GlcNAcylation and phosphorylation: a new paradigm for cellular signaling?
    Hart, G.
    FEBS JOURNAL, 2010, 277 : 14 - 14
  • [6] O-GlcNAcylation and cardiovascular disease
    Wright, JaLessa N.
    Collins, Helen E.
    Wende, Adam R.
    Chatham, John C.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2017, 45 : 545 - 553
  • [7] AMPK and O-GlcNAcylation, a new paradigm to protect the failing heart
    Dontaine, Justine
    Bultot, Laurent
    Fourny, Natacha
    Gilbert, Laura
    Marino, Alice
    Daskalopoulos, Evangelos
    Esfahani, Hrag
    Vertommen, Didier
    Balligand, Jean-Luc
    Viollet, Benoit
    Beauloye, Christophe
    Horman, Sandrine
    Bertrand, Luc
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2022, 173 : S25 - S25
  • [8] Protein O-GlcNAcylation in the heart
    Ng, Yann Huey
    Okolo, Chidinma A.
    Erickson, Jeffrey R.
    Baldi, James C.
    Jones, Peter P.
    ACTA PHYSIOLOGICA, 2021, 233 (01)
  • [9] Target protein O-GlcNAcylation
    Woo, Christina
    GLYCOBIOLOGY, 2020, 30 (12) : 1028 - 1028
  • [10] ☆AMPK and O-GlcNAcylation: a new paradigm to protect the failing hypertrophic heart
    Dontaine, Justine
    Bultot, Laurent
    Fourny, Natacha
    Gilbert, Laura
    Gelinas, Roselle
    Mailleux, Florence
    Ginion, Audrey
    Daskalopoulos, Evangelos-Panagiotis
    Esfahani, Hrag
    Vertommen, Didier
    Balligand, Jean-Luc
    Viollet, Benoit
    Beauloye, Christophe
    Horman, Sandrine
    Bertrand, Luc
    ACTA CARDIOLOGICA, 2022, 77 : 16 - 17